Adipokines and inflammatory markers in elderly subjects with high risk of type 2 diabetes and cardiovascular disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adipokines and inflammatory markers in elderly subjects with high risk of type 2 diabetes and cardiovascular disease
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-20
DOI
10.1038/s41598-018-31144-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications
- (2016) Rena M. Pollack et al. DIABETES CARE
- Serum Markers of Endothelial Dysfunction and Inflammation Increase in Hypertension with Prediabetes Mellitus
- (2016) Zhouqing Huang et al. Genetic Testing and Molecular Biomarkers
- Elevated Concentration of Interferon-Inducible Protein of 10 kD (IP-10) Is Associated With Coronary Atherosclerosis
- (2015) Toshiyuki Niki et al. International Heart Journal
- Regulation of metabolism by the innate immune system
- (2015) Denise E. Lackey et al. Nature Reviews Endocrinology
- Inflammatory Cytokines in General and Central Obesity and Modulating Effects of Physical Activity
- (2015) Frank M. Schmidt et al. PLoS One
- CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis
- (2014) Xiang Zhang et al. JOURNAL OF HEPATOLOGY
- CD26/DPP4 Levels in Peripheral Blood and T Cells in Patients With Type 2 Diabetes Mellitus
- (2013) Sang Ah Lee et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the β adrenergic system
- (2013) Gaetano Santulli et al. Frontiers in Physiology
- Age-Related Impairment in Insulin Release: The Essential Role of 2-Adrenergic Receptor
- (2012) G. Santulli et al. DIABETES
- Circulating Levels of TNF-α Are Associated with Impaired Glucose Tolerance, Increased Insulin Resistance, and Ethnicity: The Insulin Resistance Atherosclerosis Study
- (2012) Nels C. Olson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of the fat composition of a single high-fat meal on inflammatory markers in healthy young women
- (2011) Mari C. W. Myhrstad et al. BRITISH JOURNAL OF NUTRITION
- Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
- (2011) D. Lamers et al. DIABETES
- Limited Overlap Between Intermediate Hyperglycemia as Defined by A1C 5.7-6.4%, Impaired Fasting Glucose, and Impaired Glucose Tolerance
- (2011) T. Saukkonen et al. DIABETES CARE
- Systemic chemokine levels, coronary heart disease, and ischemic stroke events: The PRIME Study
- (2011) F. Canoui-Poitrine et al. NEUROLOGY
- Postchallenge Glucose, A1C, and Fasting Glucose as Predictors of Type 2 Diabetes and Cardiovascular Disease: A 10-year prospective cohort study
- (2010) H. Cederberg et al. DIABETES CARE
- A Novel RANTES Antagonist Prevents Progression of Established Atherosclerotic Lesions in Mice
- (2008) Vincent Braunersreuther et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Chemokines and Cardiovascular Risk
- (2008) Pål Aukrust et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Insulin resistance associated to obesity: the link TNF-alpha
- (2008) Iria Nieto-Vazquez et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Measurement of blood glucose: comparison between different types of specimens
- (2008) Bendix Carstensen et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Markers of endothelial dysfunction and low-grade inflammation are associated in the offspring of type 2 diabetic subjects
- (2007) Eija Ruotsalainen et al. ATHEROSCLEROSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More